Neuromodulation Devices Market Size, Growth, and Trends | 2030
市場洞察とアナリストの見解:
レポートには、現在の神経調節デバイス市場の傾向と予測期間中の予測可能な影響とともに成長見通しが含まれています。
神経調節デバイスの使用は急速に増加しており、幅広い分野で使用されています。精神神経障害および神経障害の治療のための、埋め込み型および非侵襲的技術に基づく幅広い方法。頭蓋内皮質刺激 (ICS)、経頭蓋磁気刺激 (TMS)、脳深部刺激 (DBS)、経頭蓋直流刺激 (tDCS) などの治療法は、さまざまな精神神経疾患および神経疾患にわたって有望な結果を示しています。神経調節装置は、神経系の活動を調整できる高度な医療機器です。この技術は、ジストニア、パーキンソン病、震えなどの運動障害の治療に使用されます。耳鳴り;強迫性障害;感覚障害。てんかん;膀胱制御。頭痛;慢性の痛み;脳卒中;最小限の意識状態。痙縮。そして脊髄損傷。脊髄損傷の増加や神経疾患の有病率の増加などの要因が、神経調節デバイスの市場規模の拡大に寄与しています。
市場の推進力:
高齢者人口は神経疾患にかかりやすいです。高齢者が罹患する一般的な神経障害には、神経障害、パーキンソン病、アルツハイマー病、ジストニアなどがあります。国連経済社会局によると、2022 年には世界の 65 歳以上の人口は 7 億 7,100 万人でした。高齢者人口は、2030 年までに 9 億 9,400 万人、2050 年までに 16 億人に達すると予想されています。米国やカナダなどの国では、高齢者人口の増加に伴い、運動障害や精神疾患の有病率が高くなります。パーキンソン病財団によると、パーキンソン病の症状は平均 60 歳で一般的です。
カナダ心理学会は、カナダの人口の約 2% が強迫性障害 (OCD) に罹患していると述べています。世界保健機関 (WHO) は、てんかんは発作を引き起こす神経疾患であり、世界中で約 5,000 万人が罹患していると述べています。米国神経学会によると、脳卒中は米国の死因の第 3 位であり、アルツハイマー病が第 6 位となっています。同じ情報源からの統計によると、100万人近くのアメリカ人がパーキンソン病に罹患しており、毎年少なくとも6万人の新規症例が報告されている。うつ病や慢性疼痛などの生活習慣病に加え、神経疾患の有病率の増加により、最先端の製品の採用が増加しています。
したがって、神経疾患にかかりやすい高齢者人口が増加し、疾患の有病率が増加しています。
神経科学は、脳卒中、頭痛障害、多発性硬化症、その他の重篤な症例などの疾患の治療に焦点を当てています。近年、先進国でも神経内科の熟練労働力が相対的に不足していることが確認されています。米国には 5,700 を超える病院があります。しかし、これらの病院の脳神経外科医の数は 3,700 人未満です。脳神経外科の労働力不足の主な要因は、適切な訓練を受けた脳神経外科医を適切な期間内に輩出できないことである。都市部では高度な技術を備えた神経内科施設が充実しています。しかし、地方では専門の専門家が不足しているため、提供される治療は限られています。したがって、熟練した神経外科医の不足は、神経調節デバイス市場の成長を妨げています。
レポートの細分化と範囲:
「神経調節デバイス市場分析」が実施されました。タイプ、アプリケーション、生体材料、エンドユーザーなどのセグメントを考慮して分析します。
セグメント分析:
神経調節デバイス市場は、タイプごとに外部と内部に分かれています。内部神経調節セグメントは、2022 年にはより大きな神経調節デバイス市場シェアを保持しました。しかし、外部神経調節セグメントは、2022 ~ 2030 年にかけてより高い CAGR を記録する可能性があります。 「内部神経調節」という用語は、神経系の活動を調節または変更するために、特定の神経標的に電気的、化学的、またはその他の形式の刺激を与える医療機器の使用を指します。この技術は、神経血管疾患、運動異常、てんかん、慢性疼痛、便失禁、尿失禁の治療に使用されます。
タイプ別神経調節デバイス市場 – 2022 年および 2030 年
エンドユーザー別、神経調節デバイス市場は、病院、診療所、在宅医療に分割されています。 2022 年には、病院セグメントが神経調節デバイスの市場シェアを独占しました。多数の病院や診療所の拡張と医療インフラ構築のための政府支出の増加により、現在、病院部門が市場を独占しています。さらに、人口の高齢化により慢性疼痛の有病率が高くなり、病院における神経調節デバイスの需要が高まると予想されています。
地域分析:
神経調節デバイス市場レポートの範囲は次のとおりです。主に北米(米国、カナダ、メキシコ)、欧州(スペイン、英国、ドイツ、フランス、イタリア、その他の欧州)、アジア太平洋(韓国、中国、インド、日本、オーストラリア、アジア太平洋地域のその他の地域)、中東およびアフリカ(南アフリカ、サウジアラビア、UAE、および中東およびアフリカのその他の地域)、南および中央アメリカ(ブラジル、アルゼンチン、および中南米のその他の地域) )。
収益の面では、2022 年の神経調節デバイス市場シェアは北米が独占しました。神経疾患の蔓延、研究開発への高額支出、FDA による製品承認数の増加、技術の進歩により、この地域の神経調節デバイスの需要を高めます。
競争状況と主要企業:
神経調節デバイス市場レポートは、アボット (セントルイス) などの市場の著名なプレーヤーに焦点を当てています。 Jude Medical, Inc)、LivaNova PLC、Boston Scientific Corporation、Aleva Neurotherapeutics SA、Bioventus、EnteroMedics Inc、Nevro Corporation、NeuroPace Inc、Synapse Biomedical Inc、および Neurosigma Inc. 神経調節デバイスの市場予測は、利害関係者が成長戦略を計画するのに役立ちます。これらの企業は、世界中で高まる消費者の需要に応えるために、新技術、既存製品のアップグレード、市場の拡大に重点を置いています。企業のプレスリリースによると、以下に最近の主要な開発をいくつか示します。
2023 年 8 月、メドトロニック plc は、Inceptiv 閉ループ充電式脊髄刺激装置 (SCS) の CE マーク承認を取得しました。これは、各個人の固有の生体信号を感知し、必要に応じて刺激を瞬間ごとに調整する閉ループ機能を提供する最初のメドトロニック SCS デバイスであり、日常生活の動作と調和した治療を維持します。2023 年 8 月にアボットは承認を取得しました。 FlexBurst360 療法を特徴とする新しい Proclaim Plus 脊髄刺激 (SCS) システムに対して米国食品医薬品局 (FDA) からの評価を受けています。アボット独自の BurstDR 刺激の次世代である FlexBurst360 療法は、体幹および/または四肢の 6 つの領域にわたる痛みをカバーします。これにより、個人の治療上のニーズに応じて調整できるプログラミングが容易になります。
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The neuromodulation device market, based on end user, segmented into hospitals, clinics, and home healthcare. In 2022, the hospitals segment dominated the neuromodulation devices market share.
Asia Pacific is expected to be the fastest growing region in the neuromodulation device market. The rising prevalence of neurological diseases and the development of neuromodulation devices are likely to enhance the market's growth in the coming years. China is among the most populated countries in the world, and the country has a maximum number of patients suffering from neurological disorders.
The neuromodulation device market, based on application, is segmented into metallic, polymeric, and ceramic. In 2022, the metallic segment dominated the market share. However, the polymeric segment is likely to register the highest CAGR during 2022–2030.
The neuromodulation device market, based on application, is segmented into deep brain stimulation (DBS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES), spinal cord stimulation (SCS), and vagus nerve stimulation (VNS). The spinal cord stimulation segment held the largest market share in 2022 and is expected to record the highest CAGR in the market during 2022–2030.
The neuromodulation device market, based on type, is bifurcated into external and internal. The internal neuromodulation segment held a larger neuromodulation devices market share in 2022. However, the external neuromodulation segment is likely to register a higher CAGR during 2022–2030.
US holds the largest market share in neuromodulation device market. the incidence of neurovascular diseases is rising significantly, and it is among the leading causes of death across the country. Rising incidence of neurological diseases such as Parkinson's disease (PD), increasing awareness about neurological disorders, and growing investments in developing transcranial stimulators are among the main factors driving the overall neuromodulation devices market growth in the US.
The neuromodulation device market majorly consists of the players such as Abbott (St. Jude Medical, Inc.), LivaNova PLC, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Bioventus, EnteroMedics Inc, Nevro Corporation, NeuroPace Inc, Synapse Biomedical Inc, Neurosigma Inc among others.
The factors that are driving growth of the market are the rising cases of spinal cord injury and increasing prevalence of neurological disorders.
Neuromodulation use is growing rapidly, with a wide range of implantable and noninvasive technology-based methods for the treatment of neuropsychiatric and neurological disorders. Therapies such as intracranial cortical stimulation (ICS), transcranial magnetic stimulation (TMS), deep brain stimulation (DBS), and transcranial direct current stimulation (tDCS) have shown promising results across a range of neuropsychiatric and neurological disorders. Neuromodulation devices are advanced medical instruments that can adjust the activity of the nervous system. The technology is used to treat movement disorders such as dystonia, Parkinson’s disease, and tremor; tinnitus; obsessive compulsive disorder; sensory disabilities; epilepsy; bladder control; headache; chronic pain; stroke; minimally conscious state; spasticity; and spinal cord injury.
The List of Companies - Neuromodulation Devices Market
- Abbott (St. Jude Medical, Inc.)
- LivaNova PLC
- Boston Scientific Corporation
- Aleva Neurotherapeutics SA
- Bioventus
- EnteroMedics Inc.
- Nevro Corporation
- NeuroPace Inc.
- Synapse Biomedical, Inc.
- Neurosigma, Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.